This study and article processing charges were funded by Novartis Pharmaceuticals Corp.
All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval for the version to be published.
The authors thank Chun-Lan Chang, PhD, for contributions to data interpretation and manuscript development. Medical writing support was provided by Caroline Jennermann, MS, of Optum, funded by Novartis Pharmaceuticals Corp.
At the time of the study, Engels N. Obi was an employee of Rutgers University providing services to Novartis Pharmaceuticals Corp. (NPC) and was reimbursed for travel to present research; he is now an employee of NPC. He has no conflicts to disclose.
Jason P. Swindle is an employee of Optum, Inc., which was contracted by NPC to perform the study; employment was not contingent upon this funding. He has no conflicts to disclose.
Stuart J. Turner is an employee of NPC and has no conflicts to disclose.
Patricia A. Russo provided consulting services to NPC as an employee of DataMed Services, Inc., but she is a current employee of NPC. She has no conflicts to disclose.
Aylin Altan is an employee of Optum, Inc., which was contracted by NPC to perform the study; employment was not contingent upon this funding. She has no conflicts to disclose.
Compliance with Ethics Guidelines
This study was conducted in compliance with the Health Insurance Portability and Accountability Act privacy rules.